Check out our Nasdaq-sponsored webinar titled “Drug Development’s New Model”, with experts Piet van der Graaf, SVP, Head of QSP and John Burke, PhD, Co-Founder, President, and CEO at Applied BioMath.
- Explore the intersection of biosimulation and R&D challenges: Gain insights into common R&D hurdles like high failure rates and safety concerns, and discover how biosimulation tackles these challenges through advanced mathematical modeling.
- Real-Life Case Studies: Gain insights from examples where biosimulation shaped effective therapies.
- Industry Impact: Understand how adopting biosimulation can transform pharmaceutical companies and healthcare.
- Future Perspectives: Explore opportunities for innovation in drug discovery with biosimulation.
Access the on-demand webinar now!
